ICEECE2012 Poster Presentations Diabetes (248 abstracts)
1Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW, Australia; 2St. Vincents Hospital, Darlinghurst, Sydney, NSW, Australia; 3University of New South Wales, Randwick, NSW, Australia; 4Prince of Wales Hospital, Randwick, NSW, Australia; 5Prince of Wales Hospital, Randwick, NSW, Australia; University of Adelaide, Adelaide, SA, Australia.
Introduction: The prevalence of impaired fasting glucose (IFG) in the elderly approaches 50% in some community-dwelling cohorts. We examined whether IFG is associated with a higher burden of disease, cardiovascular risk factors and circulating low-grade inflammation than in normoglycemic elderly people.
Methods/Design: Cross-sectional data of 929 participants of the Sydney Memory and Aging Study (MAS) were examined. MAS is a population-derived cohort of community-dwelling adults aged 7090 years. Normoglycemic (NG) and IFG participants were compared using contingency tables and the Chi-square test. Logistic regression and ANCOVA analyses were performed adjusted for age, sex and Body Mass Index (BMI).
Results: Mean age was 78.6 (±4.7) years; 47% had IFG, 12% had diagnosed type 2 diabetes and 4% previously undiagnosed type 2 diabetes. There were proportionately more males with IFG compared to NG (49% vs 37% males,
Conclusion: In this cohort of community-dwelling elderly, IFG was not associated with an increased burden of disease cross-sectionally. Prospective data are required to elucidate whether the moderately increased markers of inflammation accompanying IFG in this population adversely affect health outcomes during residual life span.
Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.
Funding: This work was supported, however funding details unavailable.